How much could primary human papillomavirus testing reduce cervical cancer incidence and morbidity?

ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening

(2014) HC Kitchener et al.   HEALTH TECHNOLOGY ASSESSMENT

Are women ready for the new cervical screening protocol in England? A systematic review and qualitative synthesis of views about human papillomavirus testing

(2012) M Hendry et al.   BRITISH JOURNAL OF CANCER

Pilot study will assess whether HPV test should replace smears to screen for cervical cancer

(2012) J. Wise   BMJ-British Medical Journal

A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: Extended follow up in the ARTISTIC trial

(2011) Henry C. Kitchener et al.   EUROPEAN JOURNAL OF CANCER

Human Papillomavirus Testing in the Prevention of Cervical Cancer

(2011) Mark Schiffman et al.   JNCI-Journal of the National Cancer Institute

Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study

(2010) D Mesher et al.   BRITISH JOURNAL OF CANCER

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

(2010) Guglielmo Ronco et al.   LANCET ONCOLOGY

Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-Results from the Hammersmith study

(2008) Jack Cuzick et al.   INTERNATIONAL JOURNAL OF CANCER

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

(2008) Chris J.L.M. Meijer et al.   INTERNATIONAL JOURNAL OF CANCER

Overview of Human Papillomavirus-Based and Other Novel Options for Cervical Cancer Screening in Developed and Developing Countries

(2008) Jack Cuzick et al.   VACCINE